Birzeit Pharmaceuticals Company (PEX:BPC)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.600
-0.050 (-1.37%)
At close: Sep 3, 2025
-1.37%
Market Cap98.91M
Revenue (ttm)32.41M
Net Income (ttm)9.21M
Shares Out38.76M
EPS (ttm)0.24
PE Ratio10.73
Forward PEn/a
Dividend0.04 (1.39%)
Ex-Dividend DateApr 23, 2025
Volume1,406
Average Volume5,137
Open3.600
Previous Close3.650
Day's Range3.600 - 3.600
52-Week Range3.550 - 4.350
Beta0.02
RSI39.77
Earnings DateAug 13, 2025

About PEX:BPC

Birzeit Pharmaceuticals Company manufactures and trades in various medicines in the Palestinian Authority. The company offers its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, endocrines, central nervous system, genito-urinary system, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. It also provides OTC products, such as multivitamins and minerals, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1973
Employees 300
Stock Exchange Palestine Stock Exchange
Ticker Symbol BPC
Full Company Profile

Financial Performance

In 2024, PEX:BPC's revenue was $40.65 million, a decrease of -5.74% compared to the previous year's $43.13 million. Earnings were $5.18 million, a decrease of -15.26%.

Financial numbers in USD Financial Statements

News

There is no news available yet.